Health In Tech, Inc. (NASDAQ:HIT – Get Free Report)’s share price fell 0% on Friday . The company traded as low as $0.61 and last traded at $0.63. 59,190 shares changed hands during trading, a decline of 96% from the average session volume of 1,400,806 shares. The stock had previously closed at $0.63.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen cut shares of Health In Tech from a “strong-buy” rating to a “buy” rating in a report on Saturday.
Get Our Latest Stock Report on HIT
Health In Tech Stock Down 0.0%
Health In Tech (NASDAQ:HIT – Get Free Report) last issued its quarterly earnings results on Monday, April 14th. The company reported $0.01 EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.01). The firm had revenue of $8.02 million during the quarter, compared to the consensus estimate of $6.87 million.
Hedge Funds Weigh In On Health In Tech
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Cubist Systematic Strategies LLC bought a new stake in shares of Health In Tech in the 1st quarter worth approximately $41,000. Arete Wealth Advisors LLC acquired a new position in shares of Health In Tech in the first quarter valued at $47,000. Jane Street Group LLC acquired a new position in shares of Health In Tech in the 1st quarter valued at $48,000. Finally, XTX Topco Ltd acquired a new position in shares of Health In Tech in the 1st quarter valued at $59,000.
Health In Tech Company Profile
Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.
Featured Articles
- Five stocks we like better than Health In Tech
- How to Invest in the Best Canadian StocksĀ
- Five Below Pops on Strong Earnings, But Rally May Stall
- Where Do I Find 52-Week Highs and Lows?
- Intel’s Dual Gamble: AI Innovation Now, Foundry Fortunes Later?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back
Receive News & Ratings for Health In Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health In Tech and related companies with MarketBeat.com's FREE daily email newsletter.